We prospectively evaluated clinical and demographic features in individuals with SCN1A positive Dravet syndrome over a 10-year follow-up period identifying predictors of developmental outcome and potential disease biomarkers. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.